• Publications
  • Influence
BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study
Germline BRCA1/2 testing of breast and ovarian cancer patients is growing rapidly as the result affects both treatment and cancer prevention in patients and relatives. Through the DNA-BONus study weExpand
  • 47
  • 7
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
Background:Chemotherapy in platinum-resistant ovarian cancer (PROC) aims for palliation and prolonging of progression-free survival (PFS). This study compares Health-related Quality of Life (HRQoL)Expand
  • 15
  • 2
  • PDF
Efficacy of niraparib on progression-free survival (PFS) in patients (pts) with recurrent ovarian cancer (OC) with partial response (PR) to the last platinum-based chemotherapy.
5517Background: Therapeutic paradigms for recurrent OC vary by geography. Maintenance following response to platinum-based chemotherapy (Plat) is standard in Europe, whereas in the US maintenance i...
  • 7
The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients
BackgroundTo explore quantitative metabolic and microstructural primary tumour parameters at pretreatment FDG-PET/CT and diffusion-weighted-magnetic resonance imaging (DW-MRI) in relation to clinicalExpand
  • 3
Abstract 4692: Relationships between somatic genomic alterations, tumor stage and progression-free survival in cervical cancer
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Background: Cervical cancer is a major public health problem worldwide. We have recently identified novel significantlyExpand